| 2008 JASN IMPACT FACTOR 7.505 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Science in Renal Medicine |
Department of Medicine, Indiana University, Indianapolis, Indiana
Correspondence: Dr. Sharon M. Moe, Professor of Medicine, Department of Medicine, Indiana University, 1001 W. 10th Street, OPW 526, Indianapolis, IN 46202. Phone: 317-278-2868; Fax: 317-278-2860; E-mail: smoe{at}iupui.edu
Vascular calcification is common in chronic kidney disease and associated with increased morbidity and mortality. Its mechanism is multifactorial and incompletely understood. Patients with chronic kidney disease are at risk for vascular calcification because of multiple risk factors that induce vascular smooth muscle cells to change into a chondrocyte or osteoblast-like cell; high total body burden of calcium and phosphorus due to abnormal bone metabolism; low levels of circulating and locally produced inhibitors; impaired renal excretion; and current therapies. Together these factors increase risk and complicate the management of vascular calcification.
This article has been cited by other articles:
![]() |
J.-S. Shao, S.-L. Cheng, J. Sadhu, and D. A. Towler Inflammation and the Osteogenic Regulation of Vascular Calcification: A Review and Perspective Hypertension, March 1, 2010; 55(3): 579 - 592. [Full Text] [PDF] |
||||
![]() |
Y. Oyama, J. J. Kazama, M. Fukagawa, Y. Arakawa, and I. Ezuka Ectopic ossification in the cranial dura mater in dialysis patients with secondary hyperparathyroidism NDT Plus, February 1, 2010; 3(1): 64 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Ford, L. A. Tomlinson, E. R. Smith, C. Rajkumar, and S. G. Holt Fetuin-A is an independent determinant of change of aortic stiffness over 1 year in non-diabetic patients with CKD stages 3 and 4 Nephrol. Dial. Transplant., January 14, 2010; (2010) gfp723v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Raggi, S. Vukicevic, R. M. Moyses, K. Wesseling, and D. M. Spiegel Ten-Year Experience with Sevelamer and Calcium Salts as Phosphate Binders Clin. J. Am. Soc. Nephrol., January 1, 2010; 5(Supplement_1): S31 - S40. [Abstract] [Full Text] [PDF] |
||||
![]() |
C J Ferro, C D Chue, R P Steeds, and J N Townend Is lowering phosphate exposure the key to preventing arterial stiffening with age? Heart, November 1, 2009; 95(21): 1770 - 1772. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Hage, R. Venkataraman, G. J. Zoghbi, G. J. Perry, A. M. DeMattos, and A. E. Iskandrian The scope of coronary heart disease in patients with chronic kidney disease. J. Am. Coll. Cardiol., June 9, 2009; 53(23): 2129 - 2140. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Foley Phosphate Levels and Cardiovascular Disease in the General Population Clin. J. Am. Soc. Nephrol., June 1, 2009; 4(6): 1136 - 1139. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Moe Vascular Calcification: The Three-Hit Model J. Am. Soc. Nephrol., June 1, 2009; 20(6): 1162 - 1164. [Full Text] [PDF] |
||||
![]() |
S. C. Palmer, J. C. Craig, and G. F. M. Strippoli Taking aim at targets Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1358 - 1361. [Full Text] [PDF] |
||||
![]() |
R. Villa-Bellosta and V. Sorribas Phosphonoformic Acid Prevents Vascular Smooth Muscle Cell Calcification by Inhibiting Calcium-Phosphate Deposition Arterioscler Thromb Vasc Biol, May 1, 2009; 29(5): 761 - 766. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Jean, E. Bresson, J.-C. Terrat, T. Vanel, J.-M. Hurot, C. Lorriaux, B. Mayor, and C. Chazot Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences Nephrol. Dial. Transplant., March 1, 2009; 24(3): 948 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Ix, I. H. De Boer, C. A. Peralta, K. L. Adeney, D. A. Duprez, N. S. Jenny, D. S. Siscovick, and B. R. Kestenbaum Serum Phosphorus Concentrations and Arterial Stiffness among Individuals with Normal Kidney Function to Moderate Kidney Disease in MESA Clin. J. Am. Soc. Nephrol., March 1, 2009; 4(3): 609 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Eknoyan Salivary Phosphorus Binding: A Novel Approach to Control Hyperphosphatemia J. Am. Soc. Nephrol., March 1, 2009; 20(3): 460 - 462. [Full Text] [PDF] |
||||
![]() |
M.-u. Alam, J. P. Kirton, F. L. Wilkinson, E. Towers, S. Sinha, M. Rouhi, T. N. Vizard, A. P. Sage, D. Martin, D. T. Ward, et al. Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells Cardiovasc Res, February 1, 2009; 81(2): 260 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Drueke Arterial Intima and Media Calcification: Distinct Entities with Different Pathogenesis or All the Same? Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1583 - 1584. [Full Text] [PDF] |
||||
![]() |
K. Amann Media Calcification and Intima Calcification Are Distinct Entities in Chronic Kidney Disease Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1599 - 1605. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Danziger Vitamin K-dependent Proteins, Warfarin, and Vascular Calcification Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1504 - 1510. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Palmer and G. Strippoli Reply: Vitamin D compounds in chronic kidney disease: change may be needed for good! Nephrol. Dial. Transplant., June 1, 2008; 23(6): 1789 - 1792. [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673